Sanatorio de la Mujer
About Sanatorio de la Mujer
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Pfizer
2
CanariaBio Inc.
1
Geron Corporation
1
Janssen Research & Development, LLC
1
Kartos Therapeutics, Inc.
1
Ottawa Hospital Research Institute
1
Seagen Inc.
1
Clinical Trials at Sanatorio de la Mujer
During the past decade, Sanatorio de la Mujer conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on
average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia Prevention
2011-04-01
2016-09-01
Completed
2,464
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
2016-11-21
2025-07-30
Recruiting
600
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
2019-01-15
2025-12-31
Recruiting
385
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
2019-02-07
2026-12-19
Recruiting
3,400
A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer
2019-12-17
2024-12-15
Active, not recruiting
184
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
2020-02-21
2025-11-28
Active, not recruiting
2,907
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sanatorio de la Mujer" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Pfizer" with 2 trials
sponsored, "CanariaBio Inc." with 1 trials sponsored, "Geron Corporation" with 1 trials sponsored and "Janssen Research & Development, LLC"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio de la Mujer"
#1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Genmab" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Latin American Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Sanatorio de la Mujer
According to Clinical.Site data, the most researched conditions in "Sanatorio de la Mujer" are
"Cardiovascular Disease" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Ovarian Epithelial" (1 trials), "Cervical Cancer" (1 trials) and "Fallopian Tube Adenocarcinoma" (1 trials). Many other conditions were trialed in "Sanatorio de la Mujer" in a lesser frequency.
Clinical Trials Intervention Types at Sanatorio de la Mujer
Most popular intervention types in "Sanatorio de la Mujer" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Atezolizumab" (3 trials), "Best Available Therapy (BAT)" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Ado-trastuzumab emtamsine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sanatorio de la Mujer
The vast majority of trials in "Sanatorio de la Mujer" are
8 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Sanatorio de la Mujer
Currently, there are NaN active trials in "Sanatorio de la Mujer".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Sanatorio de la Mujer,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Sanatorio de la Mujer, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".